Procedure

2018 discharge: European Medicines Agency (EMA)

2019/2073(DEC)·9th term·CONT / ENVI·DEC - Discharge procedure·CompletedProcedure completed

Subjects: 2018 discharge

Rapporteur (the Member appointed to lead Parliament's work on this text): CZARNECKI Ryszard (ECR)

Summary

Report on the 2018 discharge for the European Medicines Agency (EMA). Amendments note that most of the Agency's revenue stems from fees paid by the pharmaceutical industry and raise concerns about its independence, address the effects of the United Kingdom's withdrawal from the European Union including the relocation to Amsterdam, delays to the EU clinical trials portal and EudraVigilance, conflicts of interest, and public access to documents.

Procedure timeline

Committee amendments tabled
11 Dec 2019 – 3 Feb 2020
Procedure completed

Amendments

distinct, in window

Members

tabled at least one

Committee(s)

11 Dec 2019 – 3 Feb 2020

Dates

Plenary votes

1 roll-call votes

In plenary, Parliament usually votes in steps: first on amendments to the text (sometimes split into parts, so Members can accept one half of a sentence and reject the other), then on the text as a whole. The “main vote” is the one that adopts or rejects the text itself. Each vote below shows exactly which step it was. How voting works →

13 May 2020Passedoutcome from totals
On the decision
Official label: Décision · what was voted ↗
558 for121 against11 abstentions14 did not vote
For
Against
Abst.
Click a group to see each Member’s position.